Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1-4)

Blood (2020) 136 (Supplement 1): 3–5.

https://doi.org/10.1182/blood-2020-137438

Published: 2020

Journal Articles

Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease

Nirmish Shah, MD, Ahmar Urooj Zaidi, MD, Michael U. Callaghan, MD, Darla Liles, MD, Clarissa E. Johnson, MD, Laura M De Castro, MD MHSc

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-143434

Published: 2020

Journal Articles

In Vitro Evaluation of Thrombin Generation of Eptacog Beta (Factor VIIa, Recombinant) and Emicizumab in Congenital Hemophilia Α Plasma with and without Inhibitors

Steven W. Pipe, MD, Michael Recht, MD PhD, Michael U. Callaghan, MD, Robert F. Sidonio, Jr., MDMSc, Jerry Grandoni, PhD, Veronique Duretz, Daniel Bonzo, PhD, Jean Luc Plantier, PhD, Sean Evans, PhD RPh, Ian S Mitchell, PhD, Cedric Hermans, MDMRCP,PhD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136430

Published: 2020

Journal Articles

Sickle Cell Pain: Intervention with Capsaicin Exposure (SPICE)

Alexander Glaros, MD, Michael U. Callaghan, MD, Ahmar Urooj Zaidi, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-143276

Published: 2020

Journal Articles

Validation of Patient-Reported Vaso-Occlusive Crisis Day As a Potential Endpoint in Studies of Sickle Cell Disease

Karin Coyne, PhD, Brooke Currie, Michael U. Callaghan, MD, Kathleen W. Wyrwich, PhD, Sheryl Pease, MBA, Christine L. Baker, JD, MPH, Steven Arkin, MD, Debra D. Pittman, PhD

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-137464

Published: 2020

Journal Articles

Hemolytic Biomarkers Predict Adhesiveness of Sickle Blood Cells in a Clinical Adhesion Bioassay

Jennell White, PhD, Xiufeng Gao, MD, Michael Tarasev, Michael.tarasev@functionalfluidics.com, Ke Liu, PhD, Michael U. Callaghan, MD, Patrick C. Hines, MDPhD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-143402

Published: 2020

Journal Articles

Untreated Bleeds May Be Historically Under-Reported and More Prevalent in People with Hemophilia A with Inhibitors: An Examination of Bleed Data from a Prospective, Non-Interventional Study

Michael U. Callaghan, MD, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Victor Jimenez-Yuste, Midori Shima, MD PhD, Peter Trask, Christine L. Kempton, Craig M. Kessler, Gallia G. Levy, Elena Santagostino

Blood (2018) 132 (Supplement 1): 383.

https://doi.org/10.1182/blood-2018-99-118160

Published: 2018

Journal Articles

Longitudinal Evaluation of a Standardized P-Selectin Flow Adhesion Bioassay: Potential Role for the Assessment and Prediction of Vaso-Occlusive Episodes in Sickle Cell Disease

Ke Liu, PhD, Xiufeng Gao, MD, Jennell White, PhD, Michael U. Callaghan, MD, Patrick C. Hines, MD PhD

Blood (2018) 132 (Supplement 1): 1096.

https://doi.org/10.1182/blood-2018-99-120084

Published: 2018

Journal Articles

A Longitudinal Study to Identify and Assess Adhesion Indices during Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Jennell White, PhD, Xiufeng Gao, MD, Ke Liu, PhD, Michael U. Callaghan, MD, Patrick C. Hines, MD PhD

Blood (2018) 132 (Supplement 1): 1097.

https://doi.org/10.1182/blood-2018-99-120311

Published: 2018

Journal Articles

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Karen L. Zimowski, MD, Glaivy M. Batsuli, MD, Mark T. Reding, MD, Jatin Rana, MD, Michael U. Callaghan, MD, Kelly Tickle, MSN, APN, PPCNP-BC, Shannon L. Meeks, MD, Robert F. Sidonio, Jr., MD

Blood (2018) 132 (Supplement 1): 635.

https://doi.org/10.1182/blood-2018-99-115089

Published: 2018

Journal Articles

Learning Not to Judge a Book By Its Cover: A Case Series of Malignancy Masquerading As Common Presentations of Sickle Cell Disease

Ahmar Urooj Zaidi, MD, Lo'Rell Martin, DO, Michael U Callaghan, MD, Sharada A. Sarnaik, MD, Jeffrey W Taub, MD

Blood (2016) 128 (22): 4872.

https://doi.org/10.1182/blood.V128.22.4872.4872

Published: 2016

Journal Articles

Bleeding Events and Safety Outcomes in Patients with Hemophilia a with Inhibitors: A Prospective, Multicenter, Non-Interventional Study

Johnny Mahlangu, Johannes Oldenburg, Prof, Michael U Callaghan, MD, Midori Shima, MD PhD, Elena Santagostino, MD PhD, Michaela Lehle, PhD, Marianne Uguen, MSc, Ceri Hirst, PhD, Maggie Moore, RN, Michael Recht, MD PhD, Claudia Garcia, MD, Renchi Yang, MD PhD, Rebecca Kruse-Jarres, MD MPH

Blood (2016) 128 (22): 3800.

https://doi.org/10.1182/blood.V128.22.3800.3800

Published: 2016

Journal Articles

Concordance of DDAVP Response in Siblings with Von Willebrand Disease or Hemophilia a

Erin Ryan, BS, Madhvi Rajpurkar, MD, Carol Lum, Michael U Callaghan, MD

Blood (2015) 126 (23): 4684.

https://doi.org/10.1182/blood.V126.23.4684.4684

Published: 2015

Journal Articles

Red Cell Band 3 Content Evaluation By Eosin Maleimide (EMA) Fluorescence: Beyond Diagnosis of Dominant Hereditary Spherocytosis (HS)

Ahmar Urooj Zaidi, MD, Miguel Herrera-Martinez, BS, Gerard W. Goyette, Jr., BS, Steven Buck, MS, Manisha Gadgeel, MBBS, Arathi Mohan, Bulent Ozgonenel, MD, Michael U Callaghan, MD, Robert M. Johnson, PhD, Yaddanapudi Ravindranath, MBBS

Blood (2015) 126 (23): 3343.

https://doi.org/10.1182/blood.V126.23.3343.3343

Published: 2015

Journal Articles

A Dominant Negative Mutation (p.P214L) in ETV6 is Associated with Megakaryocyte and Erythroid Transcript Misregulation

Leila Noetzli, BS, Jesse W Rowley, PhD, Michael U Callaghan, MD, Madhvi Rajpurkar, MD, Alisa B. Lee-Sherick, MD, Christopher C. Porter, MD, Andrew S. Weyrich, PhD, Jorge A. Di Paola, MD

Blood (2015) 126 (23): 76.

https://doi.org/10.1182/blood.V126.23.76.76

Published: 2015

Journal Articles

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Ayesha N. Zia, MD, Michael U Callaghan, MD, Anju Sawni, MD, Alcesa Backos, MD, Latha Rao, MD, Meera B. Chitlur, MD, Jeanne M. Lusher, MD, Madhvi Rajpurkar, MD

Blood (2012) 120 (21): 2254.

https://doi.org/10.1182/blood.V120.21.2254.2254

Published: 2012

Journal Articles

Racial Differences In Pediatric Venous Thromboembolism

Madhvi Rajpurkar, MD, Cynthia Sabo, MSN, RN, CPNP, Ayesha Zia, MD, Michael U Callaghan, MD, Bulent Ozgonenel, MD, Meera Chitlur, MD, Jeanne M. Lusher, MD

Blood (2010) 116 (21): 3176.

https://doi.org/10.1182/blood.V116.21.3176.3176

Published: 2010

Journal Articles

Exploiting ER Stress to Eliminate Inhibitor Antibodies in Hemophilia

Michael U Callaghan, MD, Randal J Kaufman, Ph.D.

Blood (2008) 112 (11): 3087.

https://doi.org/10.1182/blood.V112.11.3087.3087

Published: 2008

Journal Articles

Thromboelastogram Platelet Mapping Accurately Predicts Bleeding Phenotype in Glanzmann Thrombasthenia

Michael U Callaghan, MD, Meera B. Chitlur, MD, Jeanne M. Lusher, MD, Madhvi Rajpurkar, MD, Patricia Fleming, RN

Blood (2008) 112 (11): 4560.

https://doi.org/10.1182/blood.V112.11.4560.4560

Published: 2008

Journal Articles

Immune Tolerance Induction in 28 Children with Hemophilia Awith Inhibitors.

Michael U. Callaghan, MD, Indira Warrier, M.D., Madhvi Rajpurkar, M.D., Jeanne Lusher, M.D.

Blood (2006) 108 (11): 1046.

https://doi.org/10.1182/blood.V108.11.1046.1046

Published: 2006

NARROW

Safety and Efficacy of Emicizumab in Persons with Hemophilia a with or without FVIII Inhibitors: Pooled Data from Four Phase III Studies (HAVEN 1-4)

Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease

In Vitro Evaluation of Thrombin Generation of Eptacog Beta (Factor VIIa, Recombinant) and Emicizumab in Congenital Hemophilia Α Plasma with and without Inhibitors

Sickle Cell Pain: Intervention with Capsaicin Exposure (SPICE)

Validation of Patient-Reported Vaso-Occlusive Crisis Day As a Potential Endpoint in Studies of Sickle Cell Disease

Hemolytic Biomarkers Predict Adhesiveness of Sickle Blood Cells in a Clinical Adhesion Bioassay

Untreated Bleeds May Be Historically Under-Reported and More Prevalent in People with Hemophilia A with Inhibitors: An Examination of Bleed Data from a Prospective, Non-Interventional Study

Longitudinal Evaluation of a Standardized P-Selectin Flow Adhesion Bioassay: Potential Role for the Assessment and Prediction of Vaso-Occlusive Episodes in Sickle Cell Disease

A Longitudinal Study to Identify and Assess Adhesion Indices during Vaso-Occlusive Crises in Adults and Adolescents with Sickle Cell Disease

Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis

Learning Not to Judge a Book By Its Cover: A Case Series of Malignancy Masquerading As Common Presentations of Sickle Cell Disease

Bleeding Events and Safety Outcomes in Patients with Hemophilia a with Inhibitors: A Prospective, Multicenter, Non-Interventional Study

Concordance of DDAVP Response in Siblings with Von Willebrand Disease or Hemophilia a

Red Cell Band 3 Content Evaluation By Eosin Maleimide (EMA) Fluorescence: Beyond Diagnosis of Dominant Hereditary Spherocytosis (HS)

A Dominant Negative Mutation (p.P214L) in ETV6 is Associated with Megakaryocyte and Erythroid Transcript Misregulation

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Racial Differences In Pediatric Venous Thromboembolism

Exploiting ER Stress to Eliminate Inhibitor Antibodies in Hemophilia

Thromboelastogram Platelet Mapping Accurately Predicts Bleeding Phenotype in Glanzmann Thrombasthenia

Immune Tolerance Induction in 28 Children with Hemophilia Awith Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only